Download PDF
Am J Perinatol 2003; 20(4): 189-194
DOI: 10.1055/s-2003-40606
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Tocolysis Does Not Improve Neonatal Outcome in Patients with Preterm Rupture of Membranes

Allahyar Jazayeri, Mary K. Jazayeri, Gary Sutkin
  • Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, Lubbock, Texas
Further Information

Publication History

Publication Date:
21 July 2003 (online)

    Permissions and Reprints

ABSTRACT

To investigate the effects of magnesium sulfate therapy in premature preterm rupture of membranes (PPROM), this retrospective cohort study of deliveries after PPROM over a 3-year period was performed. Gestational age-matched patients, who received magnesium sulfate therapy after PPROM, were compared with those who did not receive tocolysis. Deliveries within 48 hours (47 versus 22%) and a week (92 versus 44%) of PPROM occurred more frequently in those who received tocolysis. Cervical dilation and frequency of contractions were not different between the two groups. There was no difference at 24 hours in the delivery rates (36 versus 22%). Population demographics and neonatal/obstetrical outcomes were similar between the two groups except for a shorter latency in patients who received tocolysis (60 [1-245] versus 127 [1-1848] hours, median [range]). Magnesium sulfate therapy does not appear to improve maternal or neonatal outcome in PPROM and may in fact shorten the latency period.

KEYWORDS

Premature preterm rupture of membranes - latency - tocolysis

REFERENCES

  • 1 Demissie K, Rhoads G G, Ananth C V. Trends in preterm birth and noenatal mortality among blacks and whites in the United States from 1989 to 1997.  Am J Epidemiol . 2001;  154 307-315
    CrossrefPubMedGoogle Scholar
  • 2 Preterm singleton births: United States, 1989-1996. MMWR Morb Mortal Wkly Rep .  1999;  48 185-189
    Google Scholar
  • 3 Lee K S, Khoshnood B, Wall S N, Chang Y P, Hsieh H L, Singh J K. Trend in mortality from respiratory distress syndrome in the United States, 1970-1955.  J Pediatr . 1999;  134 434-440
    PubMedGoogle Scholar
  • 4 Schoendorf K C, Kiely J L. Birth weight and age-specific analysis of the 1990 US infant mortality drop: was it surfactant?.  Arch Pediatr Adolesc Med . 1997;  151 129-134
    PubMedGoogle Scholar
  • 5 Artal R, Burgeson R, Fernandez F J, Hobel C J. Fetal and maternal copper levels in patients at term with and without premature rupture of membranes.  Obstet Gynecol . 1979;  53 608-610
    PubMedGoogle Scholar
  • 6 Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement .  1994;  12 1-24
    Google Scholar
  • 7 Mercer B M, Goldenberg R L, Meis P J. The preterm prediction study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.  Am J Obstet Gynecol . 2000;  183 738-745
    CrossrefPubMedGoogle Scholar
  • 8 Mercer B M, Miodovnik M, Thurnau G R. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.  JAMA . 1997;  278 989-995
    CrossrefPubMedGoogle Scholar
  • 9 Alexander J M, Mercer B M, Miodovnik M. The impact of digital cervical examination on expectantly managed preterm rupture of membranes.  Am J Obstet Gynecol . 2000;  183 1003-1007
    CrossrefPubMedGoogle Scholar
  • 10 Crowley P, Chalmers I, Keirse M J. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials.  Br J Obstet Gynaecol . 1990;  97 11-25
    PubMedGoogle Scholar
  • 11 Higby K, Xenakis E M, Pauerstein C J. Do tocolytic agents stop preterm labor?.  <~>A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol . 1993;  168 1247-1256
    PubMedGoogle Scholar
  • 12 Larsen J F, Eldon K, Lange A P, Leegaard M, Olsen J S, Permin M. Ritodrine in the treatment of preterm labor: second Danish Multicenter Study.  Obstet Gynecol . 1986;  67 607-613
    PubMedGoogle Scholar
  • 13 Mercer B M. Management of preterm premature rupture of the membranes.  Clin Obstet Gynecol . 1998;  41 870-882
    CrossrefPubMedGoogle Scholar
  • 14 Glock J L, Morales W J. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study.  Am J Obstet Gynecol . 1993;  169 960-964
    PubMedGoogle Scholar
  • 15 Piddington D L, Kashkouli A, Buchmeier N A. Growth of mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg (2+) levels.  Infect Immun . 2000;  68 4518-4522
    CrossrefPubMedGoogle Scholar
  • 16 Pelletier C, Prognon P, Bourlioux P. Roles of divalent cations and pH in mechanism of action of nitroxoline against escherichia coli strains.  Antimicrob Agents Chemother . 1995;  39 707-713
    PubMedGoogle Scholar
  • 17 Beggs W H, Andrews F A. Role of ionic strength in salt antagonism of aminoglycoside actions on escherichia coli and pseudomonas aeruginosa.  J Infect Dis . 1976;  134 500-504
    PubMedGoogle Scholar
      >